-
Most Popular
Search Results
240 results for cmo
3 Certainties for a New American Prosperity… and One Stock Set to Profit
Uncertainty is everywhere. Just look at the fact that more than 350 S&P 500 companies cited the word “uncertainty” on their latest earnings calls, the…
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, trader! It’s time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
LCID Stock: Why Luxury EV Maker Lucid Is Running Out of Road
The Lucid Air is a billionaire’s electric ride, but there aren’t enough billionaires for Lucid to make a profit serving them.
The Secret Sauce Fueling Palantir Stock’s Meteoric Rise
Palantir stock has lost nearly 20% since hitting an all-time high in early March. It could be time to buy given its AIP platform’s growth.
Why Is Iovance Therapeutics (IOVA) Stock Down 45% Today?
Iovance Therapeutics (IOVA) stock is falling hard on Friday following the release of clinical trial data for its melanoma treatment.
IMMP Stock: Why Is Biotech Company Immutep Rocketing Higher Today?
Immutep Limited (IMMP) stock is soaring higher on Thursday despite a lack of recent news coming from the company but there is a reason why.
Why Is Tenax Therapeutics (TENX) Stock Up 149% Today?
Tenax Therapeutics (TENX) stock is rocketing higher on Thursday after getting an update on one of its U.S. medical patents.
Why Is Virios Therapeutics (VIRI) Stock Down 71% Today?
Virios Therapeutics (VIRI) stock is falling hard on Monday after revealing results from its Phase 2b study of IMC-1 in fibromyalgia.
A Solana NFT Vending Machine Gives SOL Crypto Fans Unique Opportunity
An NFT exchange is giving investors the opportunity to obtain Solana NFTs through a vending machine. Here’s what it means for SOL crypto.
VRTX Stock: The Disappointing News Sending Vertex Pharma Shares Lower
Vertex Pharma (VRTX) stock is dropping on Friday following the release of results from a Phase 2 clinical trial for VX-864.
No, Amazon and Uber Won’t Kill UPS and FedEx Stock (FDX, UPS)
Amazon and Uber won’t disrupt traditional logistics players FedEx or UPS, both boasting strong competitive advantages for the long haul.
3 Super-Duper Dividend ETFs
These dividend ETFs have dividend yields that are well above the average, and because they’re diversified funds, they offer safety to boot.
Google Just Kicked In Hollywood’s Trailer Door
Google’s Veo 3 launch marks the moment when generating Hollywood-quality video no longer requires Hollywood-scale budgets.
PayPal Stock Is Up 34% From Its 5-Year Low. It’s Time to Buy.
After several years in the wilderness, PYPL stock appears to be returning to investors’ favor, which is good news for long-time shareholders.
CERN Stock Alert: Cerner Pops 15% on Acquisition Speculation
CERN stock is popping on rumors that the company could be acquired by Oracle for $30 billion in a blockbuster deal.
Buy Stocks in These 3 Categories – or Get Left Behind
A company’s relationship with AGI is the lens through which investors now must view all stocks. And the companies that hope to survive and thrive…
APRE Stock: The Big Leukemia Study News That Has Aprea Therapeutics Skyrocketing Today
Aprea Therapeutics (APRE) stock is seeing major gains on Wednesday after revealing results from a recent Phase 1/2 trial.
What Outside App Stores Will Mean for Apple (AAPL) Stock
Though the EU’s mandate to force Apple to accept third-party app stores doesn’t appear problematic, AAPL stock still presents some concerns.
7 – 10 of 240 results
